Status:
ACTIVE_NOT_RECRUITING
Efficacy of High-intensity Exercise in Women With Prediabetes
Lead Sponsor:
Universidad Popular Autónoma del Estado de Puebla
Collaborating Sponsors:
Hospital de Especialidades 5 de mayo, ISSSTEP. Puebla, México
University of Alcala
Conditions:
Prediabetic State
Eligibility:
FEMALE
30-60 years
Phase:
NA
Brief Summary
About 382 million of adults in the world have Diabetes type 2 (DT2), and it is foreseen that this number will increase to 592 million in 2035. International Diabetes Federation (IDF) (2017) establishe...
Detailed Description
According to the latest research of the International Diabetes Federation (IDF) (2017), 352 million of adults around 20 and 79 years old (which is 7,3% of that population), could be classified as pred...
Eligibility Criteria
Inclusion
- Women diagnosed with glycosylated hemoglobin HbA1c 39-47 mmol/mol (5.7% - 6.4%), according to the primary care registry, in the last 6 months 20,21,22.
- Women older than or equal to ≥30 to ≤60 years of age.
- To have a body mass index (BMI) greater than or equal to 25 kg/m2.
- Women who do not have any cognitive limitations to understand the information sheet and instructions, and freely sign the informed consent.
Exclusion
- Uncontrolled medical problems include, but are not limited to, cardiovascular, pulmonary, rheumatological, hematological, oncological, infectious, neuromuscular, or psychiatric diseases; diabetes or another endocrine disease; immunosuppression.
- Current treatment with hormone therapy that may affect glucose metabolism.
- Current treatment with loop diuretics or thiazide diuretics.
- Current treatment with beta-blockers or peroral steroids.
- Bariatric surgery in the last 2 years.
- Women who present neuromusculoskeletal alterations that hinder or prevent the performance of the physical exercise.
- Alcohol/drug abuse at the time of inclusion.
- Pregnant or lactating women.
- Concomitant participation in another intervention study.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05435196
Start Date
April 1 2022
End Date
August 1 2024
Last Update
August 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UPAEP
Puebla City, Mexico, 72410